Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    10363903 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Ponatinib for Advanced Medullary Thyroid Cancer
Condition: Thyroid Neoplasms
Intervention: Drug: Ponatinib

Study has passed its completion date and status has not been verified in more than two years.